慢性肾脏病肌少症诊断、治疗与预防专家共识(2024年版)
Expert consensus on the diagnosis,treatment,and prevention of sarcopenia in chronic kidney disease(2024)
慢性肾脏病肌少症诊断、治疗与预防专家共识专家组 丁巍 1余晨2
作者信息
- 1. 上海交通大学医学院附属第九人民医院肾脏科,上海200011
- 2. 同济大学附属同济医院肾脏科,上海200065
- 折叠
摘要
肌肉减少症(sarcopenia),简称肌少症,是慢性肾脏病(chronic kidney disease,CKD)患者,尤其是终末期肾病(end-stage kidney disease,ESKD)患者常见的并发症,严重影响患者的生活质量和预后.然而,目前肾脏科医师对CKD患者肌少症的诊断、治疗及预防缺乏共识.为此,专家组参考现有临床研究证据,基于中国人群特征及医疗条件,围绕肌少症发病机制、诊断治疗、运动康复策略及预防等内容制定本共识.本共识是我国首个指导CKD肌少症诊治的专家共识,旨在提高肾脏专科医师对该病的认识,规范诊断及治疗.
Abstract
Sarcopenia is a common complication in patients with chronic kidney disease(CKD),especially those with end-stage kidney disease(ESKD).It significantly affects the quality of life and prognosis of the patients.However,currently,there is a lack of consensus regarding the diagnosis,treatment,and prevention of sarcopenia in CKD patients.Therefore,combining the existing clinical evidence with the characteristics of Chinese population and medical conditions,expert consensus working group constructed this consensus.The consensus focuses on the pathogenesis,diagnosis,treatment,rehabilitation strategies,and prevention of sarcopenia in CKD.It is the first in China to guide the diagnosis and treatment of sarcopenia in CKD,aiming to enhance nephrologists'understanding of sarcopenia and standardize its diagnosis and treatment.
关键词
肌减少症/肾功能不全,慢性/诊断/治疗学/预防/专家共识Key words
Sarcopenia/Renal insufficiency,chronic/Diagnosis/Therapeutics/Prevention/Expert consensus引用本文复制引用
基金项目
上海交通大学医学院附属第九人民医院牵头标准、共识、指南(CSG)培育项目(CSG202409)
上海市科委"科技创新行动计划"(23Y11908900)
上海市申康"新兴前沿技术联合攻关项目"(SHDC12022104)
出版年
2024
NETL
NSTL
万方数据